 | Immunocore (NASDAQ:IMCR) Lifted to "Buy" at Zacks Investment Research
marketbeat.com - January 12 at 3:31 AM |
 | Immunocore (NASDAQ:IMCR) Shares Down 8.6%
americanbankingnews.com - January 14 at 3:18 PM |
 | Immunocore Holdings is Now Oversold (IMCR)
nasdaq.com - January 13 at 1:20 PM |
| Immunocore (NASDAQ:IMCR) Reaches New 12-Month Low at $25.30
americanbankingnews.com - January 13 at 10:42 AM |
| Immunocore (NASDAQ:IMCR) Shares Gap Down to $30.39
americanbankingnews.com - January 10 at 12:30 PM |
| Comparing Immunocore (NASDAQ:IMCR) and Cullinan Oncology (NASDAQ:CGEM)
americanbankingnews.com - January 10 at 6:18 AM |
 | Immunocore to present at the 40th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 6 at 10:00 AM |
| Immunocore (NASDAQ:IMCR) Shares Gap Down to $35.44
americanbankingnews.com - December 27 at 12:04 PM |
 | Immunocore' ImmTAC Candidate Shows Early Response In Ovarian And Head & Neck Cancer Patients
markets.businessinsider.com - December 6 at 12:22 PM |
| Immunocore to present at the Jefferies London Healthcare Conference
finance.yahoo.com - November 11 at 8:08 AM |
| Immunocore Reports Third Quarter 2021 Financial Results and Provides Business Update
finance.yahoo.com - November 10 at 9:42 AM |
| What Kind Of Shareholders Hold The Majority In Immunocore Holdings plc's (NASDAQ:IMCR) Shares?
finance.yahoo.com - November 1 at 11:43 AM |
|
 | Lab Notes: NFlection names new CEO; Immunocore enters into cancer drug partnership
bizjournals.com - October 22 at 2:14 PM |
 | Immunocore Holdings Plc Sponsored ADR
realmoney.thestreet.com - October 22 at 12:30 AM |
| Immunocore and Medison Pharma Partner for Future Commercialization of Tebentafusp in Canada, Central Eastern Europe, and Israel
finance.yahoo.com - October 18 at 10:33 AM |
| Immunocore announces publication of phase 3 data comparing tebentafusp with investigator’s choice in The New England Journal of Medicine
finance.yahoo.com - September 22 at 8:29 PM |
| Immunocore presents data at the European Society for Medical Oncology (ESMO) Congress 2021 demonstrating a reduction in circulating tumor DNA (ctDNA) while on tebentafusp is associated with overall survival in the Phase 2 clinical trial
finance.yahoo.com - September 20 at 10:30 AM |
| Immunocore Announces Upcoming Presentations at the European Society for Medical Oncology (ESMO) Congress 2021
finance.yahoo.com - September 13 at 5:37 PM |
| Immunocore Announces UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) Accepts Marketing Authorization Application for Tebentafusp in Metastatic Uveal Melanoma
finance.yahoo.com - September 8 at 7:52 AM |
| Immunocore's Eye Cancer Candidate Under Priority Review In US, Europe
markets.businessinsider.com - August 26 at 8:47 PM |
| Immunocore Announces that U.S. Food and Drug Administration and European Medicines Agency accept Biologics License Application and Marketing Authorization Application for Tebentafusp in Metastatic Uveal Melanoma
finance.yahoo.com - August 24 at 8:46 AM |
| Immunocore Holdings Becomes Oversold (IMCR)
nasdaq.com - August 16 at 3:52 PM |
| Immunocore Reports Second Quarter 2021 Financial Results and Provides Business Update
finance.yahoo.com - August 11 at 8:16 AM |
 | Immunocore Holdings PLC ADR
wsj.com - July 28 at 9:12 AM |
| Is Immunocore Holdings plc (IMCR) A Good Stock To Buy?
finance.yahoo.com - July 27 at 11:00 PM |
| Immunocore presents clinical data further characterizing the overall survival benefit of tebentafusp in metastatic uveal melanoma at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
finance.yahoo.com - June 4 at 9:18 AM |
| Genesco, Immunocore See Activist Action
finance.yahoo.com - May 28 at 10:43 PM |
 | Immunocore Holdings Limited: Immunocore to present at upcoming investor conferences
finanznachrichten.de - May 27 at 9:32 PM |
| Immunocore to present at upcoming investor conferences
finance.yahoo.com - May 27 at 9:32 PM |
| Immunocore announces dosing of first patient with ImmTAV® bispecific molecule for chronic Hepatitis B
finance.yahoo.com - May 18 at 6:02 PM |
| Immunocore Holdings Limited: Immunocore Reports First Quarter 2021 Financial Results
finanznachrichten.de - May 12 at 8:32 AM |
| Immunocore Reports First Quarter 2021 Financial Results
finance.yahoo.com - May 12 at 8:32 AM |
| What You Need To Know About Immunocore Holdings plc's (NASDAQ:IMCR) Investor Composition
finance.yahoo.com - May 5 at 2:04 PM |
| Immunocore Announces Upcoming Presentations at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
finance.yahoo.com - April 28 at 7:24 PM |
| Immunocore presents phase 3 data comparing tebentafusp with investigator’s choice in the clinical trial plenary session at the American Association for Cancer Research 2021 Annual Meeting
finance.yahoo.com - April 12 at 5:57 PM |
| Immunocore Announces Upcoming Presentations at the American Association for Cancer Research (AACR) 2021 Annual Meeting
finance.yahoo.com - March 10 at 9:02 PM |
| Immunocore’s tebentafusp granted Breakthrough Therapy Designation for unresectable or metastatic uveal melanoma from FDA
finance.yahoo.com - February 19 at 8:23 AM |
 | Schroder Uk Pub Regulatory News
lse.co.uk - February 8 at 7:10 PM |
